Until recently, anti-angiogenic factors were considered to exert their anti-tumor effects by inhibiting the formation of new blood vessels; however, growing evidence suggests that inhibition of the VEGF/VEGFR pathway may have multiple effects including direct inhibition of tumor cell growth and immunostimulatory functions [15,16,54,58]. The gene discussed is VEGFA; the disease is neoplasm.